Constance Cepko, Ph.D., is Professor of Genetics and Neuroscience and Co-Director of the Leder Human Biology and Translational Medicine Program at Harvard Medical School. Her laboratory addresses questions regarding mechanisms of cell fate determination and has been developing gene therapy to address genetic forms of blindness. Dr. Cepko serves on the Scientific Advisory Boards of Permeon Biologics, Advanced Cell Technology and GenSight Biologics. Dr. Cepko is a member of American Academy of Arts and Sciences and member of the National Academy of Sciences.
This person is not in the org chart